RHEUMELISA ASSAY FOR SS-B/LA AUTOANTIBODIES

Antinuclear Antibody (enzyme-labeled), Antigen, Controls

LIPOGEN, INC.

The following data is part of a premarket notification filed by Lipogen, Inc. with the FDA for Rheumelisa Assay For Ss-b/la Autoantibodies.

Pre-market Notification Details

Device IDK895995
510k NumberK895995
Device Name:RHEUMELISA ASSAY FOR SS-B/LA AUTOANTIBODIES
ClassificationAntinuclear Antibody (enzyme-labeled), Antigen, Controls
Applicant LIPOGEN, INC. 10515 RESEARCH DR. Knoxville,  TN  37932
ContactDees, Phd
CorrespondentDees, Phd
LIPOGEN, INC. 10515 RESEARCH DR. Knoxville,  TN  37932
Product CodeLJM  
CFR Regulation Number866.5100 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1989-10-13
Decision Date1989-10-27

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.